We can highlight the next thriving fund investment areas, such as Biopharma, Internet. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline A-Mansia Biotech
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by the SRIW Life Sciences, Seventure Partners, Pierre Drion.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2018.
Fund Name | Location |
Actoz Soft | Seoul, Seoul-t'ukpyolsi, South Korea |
BENGBU INVESTMENT GROUP CO.,LTD | - |
Bluecrest Capital Finance | Chicago, Illinois, United States |
Charter Communications | Connecticut, Stamford, United States |
China Urban Realty Association | Beijing, Beijing, China |
Cordaid Investment Management | The Hague, The Netherlands, Zuid-Holland |
Evergreen Investment Partners | - |
Evolution VC Partners (formerly Evolution Corporate Advisors) | New York, New York, United States |
Foreis | - |
Glilot Capital Partners | Herzliya, Israel, Tel Aviv |
Huarong Huixin | - |
Jiadi Capital | - |
Lingyi Jinfu | China, Guangdong, Guangzhou |
Lupus Ventures | Friesland, Heerenveen, The Netherlands |
MDJ Group | Florida, Tampa, United States |
Otto Group | Germany, Hamburg |
Rongxing Venture Capital | Chengdu, China, Sichuan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$1M | 01 Jan 2008 | San Jose, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$1M | 01 Jan 2008 | San Jose, California, United States |